Back to All News & Events

The latest updates from TPP Alberta

Back to Messenger
July Messenger 2022, Prescribing | Posted July 14, 2022
Read time: 1 minute

A reminder about postgraduate trainee prescribing

Physicians in a postgraduate/residency program may prescribe drugs, including Type 1 TPP-monitored medications. Medical residents must obtain approval from their program director to register with TPP Alberta—the new online resident registration form and more information on how to register can be found at tppalberta.ca/register.

Once registered, medical residents will receive personalized TPP Alberta prescription forms to use when prescribing Type 1 TPP drugs.

As recommended for all prescribers, medical residents should clearly identify themselves on any prescription. The resident’s signature should be followed by their printed name and CPSA registration number. For postgraduate trainees, the residency program name and contact information must also be included. These details help with prescriber identification and ensure prescriptions are processed and dispensed promptly. Supervising physicians do not need to co-sign a prescription written by a postgraduate trainee.

Now available: the 2021-2022 TPP Annual Report

From a new name and website, to medication list updates, to new-and-improved processes, TPP Alberta has been very busy! Find out more about TPP Alberta’s most recent activities and accomplishments by reviewing the 2021-2022 TPP Annual Report.

 

Questions? Email TPP.Info@cpsa.ab.ca.

Comments for this post are now closed. If you would like to share your feedback on this topic, please email info@cpsa.ca.